Mulryne Quoted in BioWorld on Tracking Real World Data During COVID-19
October 21, 2020
Life Sciences & Healthcare Regulatory partner Jacqueline Mulryne was featured as a panelist at the UK BIA Bioscience Forum, discussing the use of real world evidence, and the increased reliance on tracking health data during a global pandemic. The conversation, as summarized in an article from BioWorld, examines the usage of this data by companies and regulators when demonstrating the safety and efficacy of new drugs.
